Copper and ceruloplasmin abnormalities in Alzheimer's disease. - Wikidata - wikimedia - TriplyDB

Copper and ceruloplasmin abnormalities in Alzheimer's disease.

Copper and ceruloplasmin abnormalities in Alzheimer's disease.

http://www.wikidata.org/entity/Q53311361

about

Importance and management of micronutrient deficiencies in patients with Alzheimer's disease Issues raised involving the copper hypotheses in the causation of Alzheimer's disease Disturbed copper bioavailability in Alzheimer's disease Copper and iron in Alzheimer's disease: a systematic review and its dietary implications.A responsive particulate MRI contrast agent for copper(I): a cautionary tale Neocortex and allocortex respond differentially to cellular stress in vitro and aging in vivo Paradigm shift in treatment of Alzheimer's disease: zinc therapy now a conscientious choice for care of individual patients.Ceruloplasmin and iron proteins in the serum of patients with Alzheimer's disease Association between Serum Copper Status and Working Memory in Schoolchildren.Specific Binding of Cu(II) Ions to Amyloid-Beta Peptides Bound to Aggregation-Inhibiting Molecules or SDS Micelles Creates Complexes that Generate Radical Oxygen Species.Impairment of interrelated iron- and copper homeostatic mechanisms in brain contributes to the pathogenesis of neurodegenerative disorders.Acute phase proteins are major clients for the chaperone action of α₂-macroglobulin in human plasma Decreased copper in Alzheimer's disease brain is predominantly in the soluble extractable fraction.Oxidation-induced structural changes of ceruloplasmin foster NGR motif deamidation that promotes integrin binding and signaling.Progress towards a consensus on biomarkers for Alzheimer's disease: a review of peripheral analytes.Recent discoveries on the functions of astrocytes in the copper homeostasis of the brain: a brief update.Characterization of biometal profiles in neurological disorders.Treatment strategies in Alzheimer's disease: a review with focus on selenium supplementation.Association Between Serum Ceruloplasmin Specific Activity and Risk of Alzheimer's Disease.Ceruloplasmin and iron in Alzheimer's disease and Parkinson's disease: a synopsis of recent studies Heavy metals and neurodegenerative diseases: an observational study.Serum Copper, Zinc, and Iron Levels in Patients with Alzheimer's Disease: A Meta-Analysis of Case-Control Studies.Copper Exposure Perturbs Brain Inflammatory Responses and Impairs Clearance of Amyloid-Beta.Association between the c. 2495 A>G ATP7B Polymorphism and Sporadic Alzheimer's Disease.Evaluation of a prototype point-of-care instrument based on monochromatic x-ray fluorescence spectrometry: potential for monitoring trace element status of subjects with neurodegenerative disease.Hepatic and hippocampus iron status is not altered in response to increased serum ceruloplasmin and serum "free" copper in Wistar rat model for non-Wilsonian brain copper toxicosis.Elevated serum copper and ceruloplasmin levels in Alzheimer's disease.Serum Iron, Zinc, and Copper Levels in Patients with Alzheimer's Disease: A Replication Study and Meta-Analyses.Plasma Proteomic Profiles of Cerebrospinal Fluid-Defined Alzheimer's Disease Pathology in Older Adults.Aspartame and Soft Drink-Mediated Neurotoxicity in Rats: Implication of Oxidative Stress, Apoptotic Signaling Pathways, Electrolytes and Hormonal Levels.Studies of copper trafficking in a mouse model of Alzheimer's disease by positron emission tomography: comparison of 64Cu acetate and 64CuGTSM.Does ceruloplasmin differential express in the brain of Ts65Dn: a mouse mode of Down syndrome?Automation of o-dianisidine assay for ceruloplasmin activity analyses: usefulness of investigation in Wilson's disease and in hepatic encephalopathy.Altered metal metabolism in patients with HCV-related cirrhosis and hepatic encephalopathy.

P2860

Q26852673-8922DAAF-F860-4395-A317-1920E0CEE5B9 Q28248217-418E5647-E949-469E-B101-ADDA80F1BE23 Q28254726-8A9EF933-5DB8-4E93-865E-E82AF1A03DE3 Q34201410-8ABFA00A-7919-44DB-A014-D6FFCA8F0A54 Q34268745-7D4F1B1C-1A24-4869-9C22-E7775D8A6853 Q34639246-45624612-10C4-4C1D-B18B-E8B06D592A2B Q35226905-5169BA39-D317-4BDA-B9ED-BADAC00B409D Q35626417-4EB0E789-7859-4D84-BF2D-50F8DDEE812A Q36102045-04888719-39F0-422B-93EC-71082113D6D0 Q36115161-A77D9C83-C7E8-436D-ACD3-C10B6C4D5D56 Q36275015-7E6561E2-FB38-4781-A6B9-AE096784E411 Q36636420-468E9C6A-7A6F-4D29-84D7-2FFD26ADFAB7 Q37283515-D64FE941-6AA0-4CAA-88B2-144C6D12D7CB Q37563576-6BAA12EE-4F81-4A1C-BC09-FC1E6B1C6824 Q38125769-3D5BBD33-C94A-4631-9305-C9581FF25B67 Q38175352-003DCF6E-EB16-427F-880F-112F79F630DD Q38197094-21C8882E-9519-4E6D-8B44-53C1E86498B6 Q38928927-6C206ED5-FF33-4234-A47D-4AEFE3239C49 Q40032173-450A3B6F-E858-4BFC-AC3F-402B3CF5AD77 Q41339641-1405C7B5-6E60-45E5-AA7D-52A77F76B49F Q41960357-CA34C6BF-C7BD-44D4-90DE-9C34172218D1 Q42019923-5A32ADAE-3FE3-4F16-AAF6-389C4D4F4883 Q42085409-2865F40F-8375-4B49-9ADB-80A056662B91 Q42791835-E165A8E3-4A88-4AE8-914B-3B9435F7C391 Q43551249-589668B7-4B71-4F26-986B-2057D19FBBE6 Q43712169-7F2C50A2-4B64-4F77-925B-8419BDB54561 Q45898364-DD87D2C7-F8D0-4638-A7EB-A87BDEBD2A24 Q46458603-CD1356B1-E8C9-4771-B394-7AFC12D54B79 Q47417067-FCB7EAA5-DCBD-4AF7-AB4F-D63821001357 Q47989477-BD84DC6F-28F8-47BE-B262-3E7A776C537F Q48004140-E7B41FEF-6018-4C54-B318-F548B0C5614C Q48867998-057ECCA9-52AC-48A8-9175-42414EA7300D Q51325096-18413F58-A2C9-4FCA-860A-2C1309E865E1 Q52150553-DEDF26E8-F7D6-4CBA-8DB9-04912F3C518E

P2860

Copper and ceruloplasmin abnormalities in Alzheimer's disease.

http://www.wikidata.org/entity/Q53311361

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh-hant

name

Copper and ceruloplasmin abnormalities in Alzheimer's disease.

@en

Copper and ceruloplasmin abnormalities in Alzheimer's disease.

@nl

type

label

Copper and ceruloplasmin abnormalities in Alzheimer's disease.

@en

Copper and ceruloplasmin abnormalities in Alzheimer's disease.

@nl

prefLabel

Copper and ceruloplasmin abnormalities in Alzheimer's disease.

@en

Copper and ceruloplasmin abnormalities in Alzheimer's disease.

@nl

P1433

Q53311361-4994A72B-72CE-4B37-9364-9E0C6F2DC8B6

P1476

Q53311361-D99BC3CA-6B7B-4AB8-9858-0D1A59BB5D7D

P2093

Q53311361-0F828990-6EC3-4807-9FC2-221866346202

Q53311361-25B4D0FE-C4C4-47D7-B14B-317DCAF39F8B

Q53311361-4910D252-4235-46A2-ABC1-3017713229CC

Q53311361-B3D016B4-9A7C-4A56-8C5D-E895E718CEB4

Q53311361-B81BE10C-BFEB-4B32-A632-5E46A2B56297

Q53311361-BC9505DD-87C0-4385-A31F-CE6BD48C355E

P2860

Q53311361-00025632-DB78-457F-8F96-8051EBE1B799

Q53311361-108A5D2D-DF81-48D2-AFF5-7BC55E659D13

Q53311361-1A072F43-ABC9-4B6C-B9A6-D43D778B34AC

Q53311361-1C288F9C-14EF-4A34-8077-AC01EA2C7DAC

Q53311361-1E00A8EA-D6A2-4923-B79A-80386F374B4B

Q53311361-1E0F1B97-1D1A-42DB-B0AA-C7781012A65A

Q53311361-2B6FC322-DD4D-44F6-AABF-DA847189C307

Q53311361-3C5F4061-5D00-45E7-ABF4-B3B8DEAB588F

Q53311361-4FEA1B49-91EC-4EE0-815B-CAC4ADED23B2

Q53311361-590FA23C-64C6-442C-893D-022BC66274C7

P304

Q53311361-A1F1F8D0-411F-4C84-93D8-03A87F33802C

P31

Q53311361-F7AE6BBE-D7E6-4833-B0D5-F49D04276B1E

P356

Q53311361-2373D4D0-EB3C-4D6D-9508-B6F66761E3AF

P407

Q53311361-07F3BDD8-24DD-4D93-AA57-1C141522B227

P433

Q53311361-61268064-1089-43D1-858E-6B3DB1EB732A

P478

Q53311361-44DDC75C-AC60-40FA-9C1E-B8C297728A23

P577

Q53311361-418CE200-3030-4008-A118-119307BE7611

P698

Q53311361-5E1E35AC-1777-4A83-AB03-96F4F742326C

P356

1533317510375083

P1433

American Journal of Alzheimer's Disease & Other Dementias

P1476

Copper and ceruloplasmin abnormalities in Alzheimer's disease.

@en

P2093

Dzintra F Celmins

http://www.w3.org/2001/XMLSchema#string

Earl A Zimmerman

http://www.w3.org/2001/XMLSchema#string

George J Brewer

http://www.w3.org/2001/XMLSchema#string

Robert Dick

http://www.w3.org/2001/XMLSchema#string

Steve H Kanzer

http://www.w3.org/2001/XMLSchema#string

Susan M Heckman

http://www.w3.org/2001/XMLSchema#string

P2860

“Mini-mental state”

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

The Clinical Dementia Rating (CDR): current version and scoring rules

Prevalence of dementia in older Japanese-American men in Hawaii: The Honolulu-Asia Aging Study.

Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice.

Treatment of primary biliary cirrhosis with tetrathiomolybdate: results of a double-blind trial.

Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial.

Excess of nonceruloplasmin serum copper in AD correlates with MMSE, CSF [beta]-amyloid, and h-tau.

The magnitude of dementia occurrence in the world.

Trace amounts of copper in water induce beta-amyloid plaques and learning deficits in a rabbit model of Alzheimer's disease

P304

490-497

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1533317510375083

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

25

http://www.w3.org/2001/XMLSchema#string

P577

2010-07-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20631161

http://www.w3.org/2001/XMLSchema#string